Guardian Pharmacy Services, Inc. Operating Income
Guardian Pharmacy Services, Inc. (GRDN) reported Operating Income of $20.64 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Income Statement
us-gaap:OperatingIncomeLoss · last filed 2026-08-06
- Guardian Pharmacy Services, Inc. operating income (loss) for the quarter ending 2026-06-30 was $20.64M, a 64.10% increase year-over-year.
- Guardian Pharmacy Services, Inc. operating income (loss) for the quarter ending 2026-03-31 was $17.68M, a 35.91% increase year-over-year.
- Guardian Pharmacy Services, Inc. operating income (loss) for the quarter ending 2025-12-31 was $30.76M, a 83.60% increase year-over-year.
- Guardian Pharmacy Services, Inc. operating income (loss) for the quarter ending 2025-09-30 was $16.35M.
- Guardian Pharmacy Services, Inc. operating income (loss) for fiscal 2025 was $72.70M.
- Guardian Pharmacy Services, Inc. operating income (loss) for fiscal 2024 was -$62.92M.
| Period end | Operating Income (Loss) 3 month | Operating Income (Loss) 6 month | Operating Income (Loss) 9 month | Operating Income (Loss) 12 month |
|---|---|---|---|---|
| 2026-06-30 | $20.64M 10-Q · filed 2026-08-06 | $38.32M 10-Q · filed 2026-08-06 | $69.08M derived: sum of 3 quarters · filed 2026-08-06 | $85.44M derived: sum of 4 quarters · filed 2026-08-06 |
| 2026-03-31 | $17.68M 10-Q · filed 2026-05-06 | $48.44M derived: sum of 2 quarters · filed 2026-05-06 | $64.79M derived: sum of 3 quarters · filed 2026-05-06 | $77.37M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-12-31 | $30.76M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-11 | $47.12M derived: sum of 2 quarters · filed 2026-03-11 | $59.70M derived: sum of 3 quarters · filed 2026-08-06 | $72.70M 10-K · filed 2026-03-11 |
| 2025-09-30 | $16.35M 10-Q · filed 2025-11-10 | $28.93M derived: sum of 2 quarters · filed 2026-08-06 | $41.94M 10-Q · filed 2025-11-10 | $58.69M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-06-30 | $12.58M 10-Q · filed 2026-08-06 | $25.59M 10-Q · filed 2026-08-06 | $42.34M derived: sum of 3 quarters · filed 2026-08-06 | -$62.27M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-03-31 | $13.01M 10-Q · filed 2026-05-06 | $29.76M derived: sum of 2 quarters · filed 2026-05-06 | -$74.85M derived: sum of 3 quarters · filed 2026-05-06 | -$57.85M derived: sum of 4 quarters · filed 2026-05-06 |
| 2024-12-31 | $16.75M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-11 | -$87.86M derived: sum of 2 quarters · filed 2026-03-11 | -$70.85M derived: sum of 3 quarters · filed 2026-03-11 | -$62.92M 10-K · filed 2026-03-11 |
| 2024-09-30 | -$104.61M 10-Q · filed 2025-11-10 | -$87.61M derived: sum of 2 quarters · filed 2025-11-10 | -$79.67M 10-Q · filed 2025-11-10 | |
| 2024-06-30 | $17.00M 10-Q · filed 2025-08-11 | $24.94M 10-Q · filed 2025-08-11 | ||
| 2024-03-31 | $7.93M 10-Q · filed 2025-05-12 | |||
| 2023-09-30 | -$6.33M 10-Q · filed 2024-11-12 | $25.42M 10-Q · filed 2024-11-12 |